|
Uses and Applications | Advantages Over Traditional Treatment | Cost Savings
Uses and Applications For Federal Government
 The Numobag™ has numerous uses for government agencies involved in health care and emergency response.
- Chemical, electrical and heat burns
- Biological-warfare related lesions
- Lesions from smallpox, anthrax and other diseases
- Large numbers of infected people
- Infectious skin lesions
Numobag™ may be used to:
- Contain biological, chemical and nuclear attacks
- Treat single or mass casualties
- Create an instant, disposable isolation unit
- Stop advancement of insidious forms of biological attack: dermal anthrax, smallpox, necrotizing fasciitis, etc.
- Heal large skin lesions
THOT™ heals more often, faster and with less scarring than traditional treatment of skin wounds. It was used to treat 9/11 World Trade Center burn victims with favorable results. The U.S. military is currently using Numobag™ in Iraq.
Clinical case studies:
Advantages Over Traditional Treatment
Numobag™ has many clinical, financial and patient-care advantages:
- Small and portable (weighs 1.7 pounds)
- Reduced staff workload
- Multiple patients treated simultaneously
- Decreased cost of overall treatment
- No cross-contamination
- Increases rate of healing
- Improved patient morale due to faster healing
- Heals advanced-stage pressure ulcers in record time
- Stimulates new blood vessel growth
- Lower cost per treatment than any other wound treatment method
- Validated to heal large skin lesions rapidly – 25 clinical studies in past 15 years support effectiveness
- Inexpensive and disposable isolation ward
- Front-line tool for reducing cross-contamination and infection of medical personnel
- Necessary for mass casualty treatment in critical initial wounds-care emergency
- Multiplies first responders’ efforts to reduce immediate overload
- Able to be stockpiled for years without maintenance or constant surveillance
Cost Savings
During an effectiveness study, Numobag™ was found to be not only more effective than traditional treatments, but also notably more cost effective.
Level 2 Ulcers
| |
Control Patients |
THOT™ Patients |
Acute care costs
Transitional care
Outpatient costs
THOT™ costs |
$7,778
$1,479
$450
$0 |
$5,002
$423
$0
$1,480 |
| Total cost/ulcer |
$9,707 |
$6,905 |
| Healed at 4 weeks |
0% |
100% |
|
Level 3 Ulcers
| |
Control Patients |
THOT™ Patients |
Acute care costs
Transitional care
Outpatient costs
THOT™ costs |
$11,126
$2,824
$1,156
$0 |
$7,651
$1,000
$130
$2,220 |
| Total cost/ulcer |
$15,106 |
$11,001 |
| Healed at 6 weeks |
0% |
80% |
|
Level 4 Ulcers
| |
Control Patients |
THOT™ Patients |
Acute care costs
Transitional care
Outpatient costs
THOT™ costs |
$14,258
$13,947
$1,845
$0 |
$11,098
$2,223
$230
$2,960 |
| Total cost/ulcer |
$30,050 |
$16,511 |
| Healed at 12 weeks |
0% |
83.3% |
|
Ostomy/Wound Management published a peer-reviewed, randomized clinical study documenting the efficacy and cost savings of Numobag™ treatments.
The cost savings of Numobag™ use results from reduced use of specialty beds, intravenous antibiotics, nursing and dressing costs, and surgical procedures. It also immediately treats Stage II wounds to prevent progression to more serious stages.
|
